Valion Bio regains Nasdaq compliance with $1 minimum bid price rule
VBIO•Nasdaq compliance regained
Valion Bio regained compliance with Nasdaq’s $1 minimum bid price rule under Listing Rule 5550(a)(2).
Nasdaq notified the company that it met the requirement by holding a closing bid of at least $1 for the required period.
Nasdaq’s listing staff closed the compliance matter.
Related News
Stellus Capital Management provides unitranche financing for Bernhard’s Revenew International deal
SCM•
Zeo Energy Enters Cooperation Agreement With Ewyze To Develop Integrated Off-Grid Power And Data-Center Infrastructure
ZEO•
